Skip to main content
logo
Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
61.30
-1.90 (-3.01%)
Sep 10, 2026, 11:59 AM HKT

Nanjing Leads Biolabs Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
213.22177.26-8.87
Revenue Growth
20.29%---
Gross Profit
213.22177.26-5.68
Operating Income
-223.32-194.53-273.38-263.23
Net Income
-266.96-211.42-301.22-362.25
Earnings Per Share
-1.37-1.21-2.01-2.50
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
1,2421,548538.72347.65
Total Debt
373.39280.56266.4867.09
Net Cash (Debt)
868.661,267272.24280.57
Net Cash Growth
-31.46%365.57%-2.97%-
Net Cash Per Share
4.477.281.811.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
--154.43-118.82-192.69
Capital Expenditures
--8.23-2.98-11.73
Free Cash Flow
--162.65-121.79-204.41
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%-64.07%
Operating Margin
-104.73%-109.75%--2969.26%
Pretax Margin
-116.47%-110.51%--4086.28%
Profit Margin
-125.20%-119.27%--4086.28%
FCF Margin
--91.76%--2305.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
50.1051.42--